<?xml version="1.0"?>
<?xml-stylesheet type="text/css" href="https://www.dolcera.com/wiki/skins/common/feed.css?303"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
		<id>https://www.dolcera.com/wiki/index.php?action=history&amp;feed=atom&amp;title=File%3ARevised_pathway_map_1.gif</id>
		<title>File:Revised pathway map 1.gif - Revision history</title>
		<link rel="self" type="application/atom+xml" href="https://www.dolcera.com/wiki/index.php?action=history&amp;feed=atom&amp;title=File%3ARevised_pathway_map_1.gif"/>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=File:Revised_pathway_map_1.gif&amp;action=history"/>
		<updated>2026-04-10T05:59:21Z</updated>
		<subtitle>Revision history for this page on the wiki</subtitle>
		<generator>MediaWiki 1.24wmf12</generator>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=File:Revised_pathway_map_1.gif&amp;diff=1716&amp;oldid=prev</id>
		<title>Vinod.singh@dolcera.com: Finasteride is well know compound for treatment of alopecia. Which inhibit the Type II 5-α-reductase activity. The figure  shows the basic SAR for 4-azasteroids at 5- -reductase (published in a review by Kenny et al). In general, a ketone in the 3-positi</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=File:Revised_pathway_map_1.gif&amp;diff=1716&amp;oldid=prev"/>
				<updated>2006-05-10T07:06:16Z</updated>
		
		<summary type="html">&lt;p&gt;Finasteride is well know compound for treatment of alopecia. Which inhibit the Type II 5-α-reductase activity. The figure  shows the basic SAR for 4-azasteroids at 5- -reductase (published in a review by Kenny et al). In general, a ketone in the 3-positi&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Finasteride is well know compound for treatment of alopecia. Which inhibit the Type II 5-α-reductase activity. The figure  shows the basic SAR for 4-azasteroids at 5- -reductase (published in a review by Kenny et al). In general, a ketone in the 3-position is preferred. Lipophilic substituents in the 17-position are thought to bind in a lipophilic pocket of the receptor. Small lipophilic groups are tolerated around the ring as well as expanding the A-ring from six to seven-membered. The size and shape of the amide substituents at C-17 may influence both selectivity between types I and II and potency at both isoforms. Other structural classes of molecules are known to bind to 5 -R including 10 and 6-azasteroids, benzoquinolinones, benzoylaminophenoxybutanoic acid derivatives, and polyunsaturated fatty acids&lt;/div&gt;</summary>
		<author><name>Vinod.singh@dolcera.com</name></author>	</entry>

	</feed>